Male breast cancer differs from female breast cancer in molecular features that affect prognoses and drug responses

CONCLUSION: The poor prognosis of MBC compared to FBC is due to numerous molecular differences and resulting drug responses.PMID:38701649 | DOI:10.1016/j.tranon.2024.101980

Source: Translational Oncology - May 3, 2024 Category: Cancer & Oncology Authors: Yangyang Li Yan Guo Fengzhi Chen Yuqing Cui Xuesong Chen Guangyue Shi Source Type: research